Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) : In the UEMS, 689 (11.7%) participants had died during the follow-up of 7.0 ± 0.4 years (median: 6.
9 years
Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) in ovarian tumor tissues (51.5% ± 5.4) compared to normal tissues (43.
9% ± 7.2), however, the differences did
Xu, Dongxiao,
Gareev, Ilgiz,
Beylerli, Ozal,
Pavlov, Valentin,
Le, Huang,
Shi, Huaizhang (2024) was constructed, incorporating
9 significantly upregulated DEMs and 211 significantly downregulated DEGs
Djumanov, Kamaliddin,
Kariev, Gayrat,
Chmutin, Gennady,
Antonov, Gennady,
Chmutin, Egor,
Musa, Gerald,
Maier, Adam,
Shumadalova, Alina (2022) , C) was 217 (77.5%) patients i.e., ASIA A-39 (13.
9%); B-74 (26.4%), and C-104 (37.1%). In 74
CONNORS, J.M.,
SAVAGE, K.J,
JURCZAK, W,
LECH-MARANDA, E.,
SMOLEWSKI, P,
WALEWSKI, J,
STRAUS, D.J.,
YOUNES, A.,
ANSELL, S.M.,
KIM, W.S.,
GALLAMINI, A.,
ALEKSEEV, S.,
ILLÉS, A.,
ROSTA, A.,
PICARDI, M.,
ZINZANI, P.L.,
OKI, Y.,
FELDMAN, T.,
BARTLETT, N.L.,
CHEN, R.,
RAMCHANDREN, R.,
CUNNINGHAM, D.,
RADFORD, J.,
JOSEPHSON, N.C.,
SONG, E.,
SACHS, J.,
JOLIN, H.A.,
HUEBNER, D.,
LIU, R.,
LIPATOV, O.N. (2018) [CI], 78.8 to 85.0)
and 77.2% (95% CI, 73.7 to 80.4), respectively, a difference of 4.
9 percentage
-inflammatory and antiarrhythmic [7], analgesic [8], hepatoprotective [
9], antihyperglycemic
[10], and antioxidant [11] activity